Cannabis Science, Inc  - CBIS OTC - Trading Alert

Bottom Formed -Target Price $0.10 - A Double

Completion of the 60-acre Industrial Hemp Project Planted on the 250 acre

Q2 UPDATE - Consortium Formed

Stocks To Watch

  • Legalize Weed - Once In Lifetime Opportunity

  • These shares have recently soared from 1 cent to over 11 cents and consolidated.

  • We expect a rapid rise in price with a target now placed at $0.10 cents.

  • The company's dynamic management team has driven this successful company to unexpected heights

  • The company rapidly expanding into Bio  Med -Transdermal Patch Released  - COPD / Asthma Treatment

  • Seeding 350 acres to begin -  Fact Sheet CBIS

Revenues for Legal Cannabis Operations Continue To Rise Along with Growing Demand For CBD Based Products
Palm Beach, FL, United States (ABN Newswire) - In an article published on Forbes last week*, Hemp-derived cannabidiol (CBD) is projected to be a billion-dollar market in just three years, according to a new report by Brightfield Group*. Revenues being generated from the legal cannabis and marijuana market continues to push upward as leaders throughout the industry announce positive financial results and aim at surpassing initial benchmarks set last year. This growth in the multi-billion market is providing strong revenue potentials for companies such as: PotNetwork Holding Inc. (OTCMKTS:POTN), Canna Consumer Goods, Inc. (OTCMKTS:CBMJ), Hemp, Inc. (OTCMKTS:HEMP), Medical Marijuana, Inc. (OTCMKTS:MJNA), Cannabis Science Inc. (OTCMKTS:CBIS)

PotNetwork Holding Inc. (OTCMKTS:POTN) announced today that the Company has officially retained the auditing services East West Accounting Services, LLC, a Public Company Accounting Oversight Board (PCAOB) registered CPA firm, based out of South Florida. The firm will provide a methodical review and analyzation, to deliver a detailed report of the Company's recent revenues and provide credible verification. Read this and more news for POTN at: http://www.marketnewsupdates.com/news/potn.html 

East West Accounting Services, LLC is a Public Company Accounting Oversight Board (PCAOB) registered CPA firm, which provides audit, review, and consulting services to smaller capitalized public companies that are required to provide financial information with the Security and Exchange Commission.

Management has long strategized the initiation of a PCAOB audit, whereas transparency is key to the Company's strategy for growth and fortification. Strategically, management prepared for a level by which the time and money required to proceed was warranted. A a string of positive and profitable corporate events are the catalyst for Diamond CBD's achievement of this level, by which the Company has taken a proactive approach to deepen accountability in the public marketplace. 

"We believe that the timing for this action is now. In consideration of the amount of momentum built up over the past 6 months, coupled with reported revenues of $5,077,625 for the first 6-months of fiscal 2017, the only logical next step was to initiate the auditing process, whereby the market can recognize the significance and legitimacy of the Company's position, enabling the stock to begin better reflecting the Company's true growth in value." Stated, Gary Blum, Chief Executive Officer, PotNetwork Holding Incorporated.

In other industry developments and market performances of note:

Canna Consumer Goods, Inc. (OTCMKTS:CBMJ) Developments: Canna Funding Solutions who provides advertising and marketing funding for companies in the cannabis sector announced today that they have purchased $100,000.00 in media placements with premier cannabis broadcasting company Canna Broadcast Media/Loudmouth News http://cannabroadcastmedia.com/

The mainstream media will be used to promote companies that we seek to invest in during the MJAC2017 Investorshub International Cannabis Conference powered by Canna Broadcast Media in Los Angeles Sept. 1st-2nd 2017 http://mjac2017.com/

Canna Broadcast Media/Loudmouth News who has established relationships in Radio, Print, TV, and online media on a national basis produces several cannabis based content programs including Loudmouth News currently cleared to air on over 700 radio stations nationwide.

Hemp, Inc. (OTCMKTS:HEMP) announced this week The Hemp University will hold its 4th educational symposium entitled: The Hemp Oil Event (The Art & Science of CBD Oil) on Saturday, September 30, 2017 from 8:30am - 5:00pm. The event will be held at the Peachtree Hills Country Club, 3512 Peachtree Hills Road, Spring Hope, NC 27882. The educational symposium, The Art & Science of CBD Oil, will bring attendees up to speed on all business and scientific aspects of Industrial Hemp CBD cannabinoids by disseminating current, reliable information that continues to shape the revolutionary CBD market.

Medical Marijuana, Inc. (OTCMKTS:MJNA) announced last week that its subsidiary, Kannaway LLC the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products is holding an exclusive Red-Carpet Event in Phoenix, AZ this weekend, August 26th. The Red-Carpet Event provides a unique opportunity to network with top Kannaway leaders, the company's executive team and other industry professionals. Participants will hear from executive team members, including Kannaway CEO Blake Schroeder, President Brad Tayles and CEO of Kannaway parent company Medical Marijuana, Inc., Dr. Stuart Titus. Additionally, the Red-Carpet Event will provide Kannaway business owners with exclusive opportunities to accelerate their success as brand ambassadors by hearing from some of the top leaders and highest income earners.

Cannabis Science, Inc. (OTCMKTS:CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, and Free Spirit Organics Native American Corporation (FSO NAC) are announced late last week significant comprehensive educational, economic, and property development plans are underway for its 250-acre CBIS/FSO NAC MBS industrial hemp project. To date, there have been approximately 25-30 part-time workers from the community hired so far, and it is expected that another 50-75 people will be hired before the harvest is completed. The harvesting process is very labor intensive and very seasonal until the staggering process has been completed for year-round harvesting.

DISCLAIMER: MarketNewsUpdates.com (MNU) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. MNU is NOT affiliated in any manner with any company mentioned herein. MNU and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. MNU's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. MNU is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed MNU has been compensated twenty-five hundred dollars for news coverage of the current press release issued by PotNetwork Holding Inc by a non-affiliated third party. MNU HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MNU undertakes no obligation to update such statements.

Article in Forbes, link: 
http://www.abnnewswire.net/lnk/9498EV7T 

Brightfield Group report, link: 
http://www.abnnewswire.net/lnk/WUOZ3YX1 

SOURCE MarketNewsUpdates.com





Cannabis Science Launches a Global Consortium and Announces Updates on Its Drug Development Initiatives and Research Collaborations

IRVINE, CA--(Marketwired - Aug 23, 2017) -  Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the launch of the Cannabis Science Global Consortium and to provide updates on the Company's drug development initiatives and research collaborations.

The Cannabis Science Global Consortium provides the Company with a framework to cooperate and collaborate with stakeholders worldwide. "The objective of our consortium is to harness the collective expertise of our global partners to investigate the use of Cannabinoids for the treatment of a variety of indications, including cancers, neurological conditions, pain management, the treatment of HIV and AIDS, and epilepsy," stated Mr. Raymond C. Dabney, President, Chief Executive Officer, Co-founder, and Director of Cannabis Science. "The Cannabis Science Global Consortium will link universities, foundations, corporations, and individuals to share research, ideas, and other relevant information, as well as to implement a cutting-edge research program to develop medicines and delivery mechanisms from bench-to-bedside." The Cannabis Science Global Consortium will also enable the Company to more strategically coordinate its initiatives, including those focused on education, job creation, and skills training.

 Cannabis Science is aggressively expanding the Company's network of research centers. Negotiations are ongoing with several academic institutions in the United States and internationally to establish new, collaborative research agreements. These contracts will focus on several indications, and are expected to expand the research funded and directed by the Company. In addition, Cannabis Science will develop multi-center, clinical trial networks with cannabinoid drug development.

 Cannabis Science currently has several research programs underway that have produced initial results that are critical in the Company's early phase cancer drug development plan. "These initial results are better than expected and are helping Cannabis Science refine our drug development program," stated Dr. Allen Herman, Chief Medical Officer of Cannabis Science. "Based on our progress to date, we expect to conclude pre-clinical work on a few cannabinoids over the next several months, and begin clinical trials in 2018. This timeline is consistent with the Company's overall development strategy."

 There are three primary elements in Cannabis Science's drug development program: (1) Defining the effectiveness and specificity of cannabinoids being tested; (2) Identifying and testing drug delivery mechanisms; and (3) Testing and evaluating the impact of co-interventions, and the application of additional diagnostic and/or therapeutic procedures to participants in our randomized controlled trials. The Company's initial results point to the importance of drug delivery systems and the impact of co-interventions.

 "These initial experiments follow the outlines of the proposed research described in the 2016 National Academies of Sciences, Engineering, and Medicine Report on the use of Cannabinoids in medical care," said Dr. Herman "This work defines the vital early steps in our drug development program that will bring new pharmaceuticals to the treatment of many diseases."

About Cannabis Science, Inc.

Cannabis Science, Inc. takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. Cannabinoids have an extensive history dating back thousands of years, and currently, there are a growing number of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness. Our initial focus is on cancers, HIV/AIDS, and neurological conditions. The Company is proceeding with the research and development of its proprietary drugs as a part of this initial focus: CS-S/BCC-1, CS-TATI-1, and CS-NEURO-1, respectively


MORE


Breaking News: CBIS/FSAO NAC Harvest Planning Session Held Yesterday Has Accelerated the Completion of the 60-acre Industrial Hemp Project Planted on the 250 acre CBIS/FSO NAC MBS001 Plot Currently Under Harvest

IRVINE, CA--(Marketwired - Aug 17, 2017) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, and Free Spirit Organics Native American Corporation (FSO NAC) is pleased to announce that after yesterday's planning session the group has accelerated the completion of the 60-acre project planted on the 250-acre CBIS/FSO NAC MBS001 plot currently underway. 

The 2017 CBIS/FSO NAC MBS001 harvest schedule has been accelerated to immediately complete harvesting the 15-acre Phase 1 immediately. The Phase 2 harvest will begin and be completed very shortly thereafter. The management group is now hiring approximately 25 additional local workers to assist in this massive endeavor, and this direct community job creation initiative is a very important part of its Native American economic development plan for our industrial hemp project on San Joaquin Sovereign Tribal Fee land MBS, California.

"The 2017 CBIS/FSO NAC MBS001 harvest is going much better than expected, with the plants growing very fast," stated Cannabis Science CEO and CO-Founder, Mr. Raymond C. Dabney. "Many are over 6 feet tall and 5 feet wide right now. They were all planted about ten feet apart and now they are beginning to grow into each other and are nearing peak growth. This is a good problem to have when your plants are over 5 to 6 feet tall and over 5 feet wide and there are literally rows and rows of trees growing in sync with the branches so heavy at the bottom they are beginning to break off. Some of the larger branches are beginning to touch the ground leading to the accelerated harvest schedule.

"The timing of harvest is very important because at this point of the growth cycle we can maximize production and extraction usage profiles. We are bringing in extra equipment and arranging additional secure storage space to handle this large amount of raw product. The additional equipment needed for extraction of industrial and medicinal oils and fibrous products of this Hemp crop is being acquired now and some of the on-site equipment is being retrofitted now for such a mass production on the site, this will enable a much larger processing ability to start immediately.

"The 2017 CBIS/FSO NAC MBS001 harvest is still expected to yield approximately 70,000-pounds of raw inventory with wholesale numbers around $500.00 per lb. Again, there is a possible high demand for quantity and high quality profiles that can create a considerable increase in value for the initiative. The Native American initiative is certainly one of our key projects and now is the time that loyal shareholders have been waiting for. This is another key indicator that our growth schedule is on track and our success is at hand," stated Cannabis Science CEO and CO-Founder, Mr. Raymond C. Dabney.

About Cannabis Science, Inc.
Cannabis Science, Inc. takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. Cannabinoids have an extensive history dating back thousands of years, and currently, there are a growing number of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness. Our initial focus is on skin cancers, HIV/AIDS, and neurological conditions. The Company is proceeding with the research and development of its proprietary drugs as a part of this initial focus: CS-S/BCC-1, CS-TATI-1, and CS-NEURO-1, respectively.


 

Forward and Cautionary Statement - Disclaimer


About Marijuana Stock Reporting.net 
MarijuanaStockReporting.net is a subsidiary of Target Publishing Inc, and is a leading publisher of todays market and investment news, commentary, proprietary research and videos from seasoned journalists, analysts and contributors covering the financial markets and global economies. We have been paid by a third party to wite this article  Leveraging our extensive distribution network and social media presence, we have cultivated a valuable audience of engaged market enthusiasts, which in turn delivers a variety of unique oppXortunities for industry partnerships, corporate communications, market exposure and investment. The article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility.

A complete disclaimer can be viewed HERE






 










 

 

 

 

 

 

 

 

 

 

 

 

X